Vimarsana
Biggest News Aggregation in the World

Page 2 - Lori Bisson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lori Bisson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lori Bisson Today - Breaking & Trending Today

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break -February 23, 2024 at 08:50 am EST - Vimarsana News

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break -February 23, 2024 at 08:50 am EST

Live webcast with Lori Bisson, Chief Executive Officer of Autonomix, on Thursday, February 29th at 12:00 PM ET THE WOODLANDS, TX, Feb. 23, 2024 -- Autonomix Medical, Inc. , a medical device...

Autonomix Secures Principal Investigators and Completes - Vimarsana News

Autonomix Secures Principal Investigators and Completes

Proof-of-concept (PoC) human clinical trial targeting multi-billion-dollar pancreatic cancer market through transvascular RF ablation Company...

Autonomix Begins Human POC Clinical Trial Targeting - Vimarsana News

Autonomix Begins Human POC Clinical Trial Targeting

Site initiation completed for first study ever to evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with...

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones - Vimarsana News

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones

Company developing potential breakthrough technology for the nervous system Initially targeting multi-billion-dollar pancreatic cancer market On track to commence first study ever to evaluate...

Autonomix Medical, Inc. Reports Third Quarter FY2024 - Vimarsana News

Autonomix Medical, Inc. Reports Third Quarter FY2024

Company developing potential breakthrough technology for the nervous system Initially targeting multi-billion-dollar pancreatic cancer market On...